Shiok Meats
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Shiok Meats was a Singapore cultivated seafood and meat company founded in 2018 by Dr. Sandhya Sriram and Dr. Ka Yi Ling, using cellular agriculture to grow slaughter-free seafood — shrimp, crab, lobster, crayfish — from cells (the name is Singaporean slang for 'delicious'). It was Southeast Asia's first cell-based seafood company and the first in the world to produce cell-based shellfish, unveiling the world's first cell-based crab meat in 2021. It raised US$30 million from a global suite of investors and, in August 2021, made the first-ever acquisition in the cultivated meat space, taking 90% of Gaia Foods (Southeast Asia's first cell-based red meat startup). On March 13, 2024 it was acquired by Singapore-based UMAMI Bioworks in a share-for-share transaction.
02 / Shiok Meats FAILURE REASONS
Why it was acquired
Shiok Meats wasn't a failure — it was a sector consolidation. The cultivated-protein industry went through a brutal correction after 2022: funding dried up, commercialization timelines stretched, and investor Agronomics fully wrote down its Shiok Meats position in its June 2022 audited results. Rather than die, Shiok merged with UMAMI Bioworks — a Singapore cultivated-seafood company using novel stem cell technology, machine learning and automation — to combine UMAMI's production platform with Shiok's pioneering crustacean cell cultivation. The share-for-share deal (March 13, 2024) aimed at go-to-market synergies, expanded commercial opportunities and faster regulatory approvals. The acquisition price tells the story of the sector: Agronomics' 0.71% stake in UMAMI was carried at just £0.378 million.
03 / EVENT HISTORY
Events in the structured record
- Acquisition
Shiok Meats was acquired.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / AFTERMATH
Lessons
Shiok Meats' lesson is about timing in deep-tech food: being first to the science doesn't mean being first to the market. It pioneered cell-based shellfish and even made the sector's first acquisition, but the commercialization gap — scale-up, cost-down, regulatory approval — outlasted the funding cycle, and the investor's write-down preceded the rescue merger. The lesson: in capital-intensive biology businesses, plan for the funding winter before it arrives; and consolidation at distressed valuations, while painful, can be the rational endgame when two pioneers' technologies genuinely complement each other.